Medicure Inc. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Medicure Inc.

Medicure Inc.

Medicure Inc.
Stock Exchange	Other OTC
EPS	$0.02
Market Cap	$57.69 M
Shares Outstanding	15.74 M
Public Float	9.79 M

Medicure Inc.
Stock Exchange	Toronto Ventures Stock Exchange
EPS	CAD0.02
Market Cap	CAD75.41 M
Shares Outstanding	15.52 M
Public Float	12.82 M

Profile

Address	1250 Waverley Street Winnipeg Manitoba R3T 6C6 Canada
Employees	-
Website	http://www.medicure.com
Updated	07/08/2019
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of human therapeutics. It focuses on the marketing and distribution ofits acute care cardiovascular drug, AGGRASTAT. The company was founded by Albert D.

Financials

Gerald P. McDole

Independent Director

Bert D. Friesen

Chairman, President & Chief Executive Officer